Last Price$70.5(2.1%)
Market Cap$13.4B
1M Return
10.9%
vs (8.2%) S&P 500
YTD Return
(28.1%)
vs 17.5% S&P 500
1Y Return
(18.0%)
vs 8.9% S&P 500
3Y Return
(7.2%)
vs 32.5% S&P 500
BMRN Momentum Rating
BMRN Momentum rating
3.4
BMRN Momentum rating performance
BMRN Price Performance and Momentum
Crunching data... Almost there!
Competing with BMRN Stock Price Performance
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Momentum score | Last Price | 52w high | 52w low | 1d change | 1w change | 1m change | 3m change | 6m change | 1y change | 3y change | 5y change | 10y change | 3y CAGR | 5y CAGR | 10y CAGR | % of 52w high | % of 52w low |
$13.4B | 3.4 | $70.5 (2.1%) | $93.8 | $61.3 | (2.1%) | (0.0%) | 10.9% | 6.9% | (16.9%) | (18.0%) | (7.2%) | (18.9%) | (38.4%) | (2.5%) | (4.1%) | (4.7%) | 75.1% | 115.1% | |
$124.8B | 3.0 | $488.3 (2.3%) | $516.7 | $392.8 | (2.3%) | 0.4% | 7.3% | 4.3% | 2.9% | 17.8% | 106.5% | 121.6% | 298.2% | 27.3% | 17.3% | 14.8% | 94.5% | 124.3% | |
$77.0B | 4.1 | $718.2 (3.6%) | $1,200.2 | $663.0 | (3.6%) | 6.3% | 8.1% | (7.0%) | (37.0%) | (25.4%) | 11.9% | 54.7% | 69.4% | 3.8% | 9.1% | 5.4% | 59.8% | 108.3% | |
$34.4B | 9.1 | $580.4 1.7% | $671.8 | $356.0 | 1.7% | (6.6%) | (8.7%) | (4.2%) | 8.0% | 50.8% | 108.6% | 333.8% | 2,423.6% | 27.8% | 34.1% | 58.6% | 86.4% | 163.0% | |
$30.7B | 4.6 | $238.7 2.4% | $300.6 | $143.3 | 2.4% | (1.7%) | (11.2%) | (6.1%) | (8.8%) | 60.1% | 54.1% | 134.3% | 110.2% | 15.5% | 18.6% | 7.7% | 79.4% | 166.6% | |
$24.0B | 5.8 | $98.4 (6.6%) | $126.9 | $78.4 | (6.6%) | (10.3%) | (14.1%) | (17.6%) | (0.9%) | 2.2% | (26.5%) | 209.9% | 600.1% | (9.8%) | 25.4% | 47.6% | 77.5% | 125.6% | |
$14.5B | 2.3 | $32.5 (0.9%) | $33.9 | $24.1 | (0.9%) | (2.6%) | 1.3% | 29.7% | 18.6% | 11.2% | (8.4%) | (19.0%) | (19.0%) | (2.9%) | (5.1%) | (5.1%) | 95.9% | 134.6% | |
$14.2B | 7.6 | $68.1 (4.3%) | $83.4 | $51.2 | (4.3%) | (2.3%) | 2.6% | (6.1%) | 7.8% | 12.0% | (7.9%) | (5.3%) | (24.4%) | (2.7%) | (1.1%) | (2.8%) | 81.6% | 133.0% | |
$13.8B | 7.5 | $304.4 (4.2%) | $410.0 | $228.3 | (4.2%) | (1.4%) | (13.8%) | (15.9%) | (12.1%) | 22.0% | 76.0% | 223.9% | 86.9% | 20.7% | 26.5% | 6.5% | 74.2% | 133.4% | |
$13.3B | 8.0 | $18.5 2.8% | $31.9 | $2.4 | 2.8% | (3.1%) | (3.0%) | (1.4%) | (18.5%) | 330.2% | 563.1% | 878.8% | 68.3% | 87.9% | 57.8% | 5.3% | 57.9% | 774.1% | |
$1,846.9M | 9.0 | $226.7 0.0% | $246.0 | $129.5 | 0.0% | 2.0% | 23.3% | 4.7% | 40.9% | 39.9% | (6.5%) | 45.2% | 700.5% | (3.3%) | 7.7% | 29.7% | 92.1% | 175.0% |
FAQ
1. What is BioMarin Pharmaceutical Inc. (BMRN) 1-month return?
BioMarin Pharmaceutical Inc. (BMRN) 1-month return is 10.9%, compared to the (8.2%) return of the S&P 500.
2. What is BioMarin Pharmaceutical Inc. (BMRN) year-to-date (YTD) return?
BioMarin Pharmaceutical Inc. (BMRN) YTD return is (28.1%), compared to the 17.5% return of the S&P 500.
3. What is BioMarin Pharmaceutical Inc. (BMRN) 1-year return?
BioMarin Pharmaceutical Inc. (BMRN) 1-year return is (18.0%), compared to the 8.9% return of the S&P 500.
4. What is BioMarin Pharmaceutical Inc. (BMRN) 3-year return?
BioMarin Pharmaceutical Inc. (BMRN) 3-year return is (7.2%), compared to the 32.5% return of the S&P 500.